GT Biopharma to Host Live Company Presentation on the Development of TriKE® Platform for Cancer Treatment, September 11, 2026
GT Biopharma, a clinical stage immuno-oncology company, announced a live presentation on September 11, 2026, detailing clinical progress of its proprietary TriKE® natural killer cell engager platform for cancer treatment. The presentation will cover advancements in treating blood cancers and solid tumors, dosing insights, competitive positioning, a…